Courtney Hazelrigg, OTRL | |
1407 Ashley River Road, Charleston, SC 29407-5305 | |
(843) 769-0663 | |
(843) 769-0665 |
Full Name | Courtney Hazelrigg |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 1407 Ashley River Road, Charleston, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114026408 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 2944 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Courtney Hazelrigg, OTRL 1407 Ashley River Road, Charleston, SC 29407-5305 Ph: (843) 769-0663 | Courtney Hazelrigg, OTRL 1407 Ashley River Road, Charleston, SC 29407-5305 Ph: (843) 769-0663 |
News Archive
Biomet, Inc. announced today preliminary financial results for its fourth quarter and fiscal year ended May 31, 2012. The final results for the three and twelve months ended May 31, 2012 will be made available to the public with the filing of Biomet's Form 10-K for fiscal year 2012 and will include the finalization of a non-cash goodwill and intangible asset impairment charge as further described below and certain income tax accounts.
Researchers at McMaster University have developed the first assessment tool of its kind for evaluating risks faced by Canadians suffering from a rare and often fatal bleeding disorder.
Long before humans figured out how to create colors, nature had already perfected the process - think stunning, bright butterfly wings of many different hues, for example. Now scientists are tapping into those secrets to develop a more environmentally friendly way to make colored plastics. Their paper on using structure - or the shapes and architectures of materials - rather than dyes, to produce color appears in the ACS journal Nano Letters.
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
› Verified 5 days ago
Mr. Shawn Styles, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1941 Savage Road, Suite 400c, Charleston, SC 29407 Phone: 843-571-2700 Fax: 843-571-2124 | |
Mira Kraft, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2230 Ashley Crossing Dr, Charleston, SC 29414 Phone: 843-766-5228 | |
Mrs. Alysson Miller Goodwin, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 29 Race St, Charleston, SC 29403 Phone: 318-792-1696 | |
Amanda Prester Beacham, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 45 Sycamore Ave Apt 917, Charleston, SC 29407 Phone: 843-900-6202 Fax: 843-574-8858 | |
Mary Katherine Melroy, O.T.R. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 236 Confederate Cir, Charleston, SC 29407 Phone: 843-718-5898 | |
Amanda Zoccolo, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 637 Highwood Cir, Charleston, SC 29412 Phone: 678-516-2709 | |
Julia Gilkerson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Colleton Dr, Charleston, SC 29407 Phone: 843-991-7709 |